دورية أكاديمية
Results of the FLAC European Database of Metastatic Castration-Resistant Prostate Cancer Patients Treated With Docetaxel, Cabazitaxel, and Androgen Receptor-Targeted Agents
| العنوان: | Results of the FLAC European Database of Metastatic Castration-Resistant Prostate Cancer Patients Treated With Docetaxel, Cabazitaxel, and Androgen Receptor-Targeted Agents |
|---|---|
| المؤلفون: | Ozguroglu, Mustafa, DELANOY, Nicolas, BELLMUNT, Joaquim, OUDARD, Stephane, ANGELERGUES, Antoine, EFSTATHIOU, Eleni, GYFTAKI, Revekka, WYSOCKI, Piotr Jan, LAINEZ, Nuria, GONZALEZ, Iria, CASTELLANO, Daniel E., GARCIA CARBONERO, Iciar, FLECHON, Aude, BORREGA, Pablo, GUILLOT, Aline, CAMPOS BALEA, Begona, LE MOULEC, Sylvestre, ESTEBAN, Emilio, MUNARRIZ, Javier, RUBIO, Gustavo, BIRTLE, Alison J. |
| المساهمون: | 44333 |
| سنة النشر: | 2018 |
| مصطلحات موضوعية: | Tıp, Onkoloji, ONKOLOJİ, Klinik Tıp, Klinik Tıp (MED), ÜROLOJİ VE NEFROLOJİ, Nefroloji, Sağlık Bilimleri, Dahili Tıp Bilimleri, İç Hastalıkları |
| الوصف: | Several agents have demonstrated an overall survival (OS) benefit in metastatic castration-resistant prostate cancer (mCRPC); however, optimal sequencing is unknown. Retrospective analysis of data from 574 mCRPC patients showed increasing OS with the number of therapies provided; a sequence including docetaxel, cabazitaxel (CABA), and an androgen receptor-targeted agent (ART) provided the greatest benefit. Prior administration of ART did not appear to influence CABA activity. These findings will help guide treatment decisions in daily practice. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| تدمد: | 1558-7673 |
| العلاقة: | CLINICAL GENITOURINARY CANCER; ANGELERGUES A., EFSTATHIOU E., GYFTAKI R., WYSOCKI P. J. , LAINEZ N., GONZALEZ I., CASTELLANO D. E. , Ozguroglu M., GARCIA CARBONERO I., FLECHON A., et al., "Results of the FLAC European Database of Metastatic Castration-Resistant Prostate Cancer Patients Treated With Docetaxel, Cabazitaxel, and Androgen Receptor-Targeted Agents", CLINICAL GENITOURINARY CANCER, cilt.16, sa.4, 2018; av_0c779b22-45b8-4270-ad53-883720639106; vv_1032021; http://hdl.handle.net/20.500.12627/14029Test; https://doi.org/10.1016/j.clgc.2018.02.016Test; 16 |
| DOI: | 10.1016/j.clgc.2018.02.016 |
| الإتاحة: | https://doi.org/20.500.12627/14029Test https://doi.org/10.1016/j.clgc.2018.02.016Test https://hdl.handle.net/20.500.12627/14029Test |
| رقم الانضمام: | edsbas.C822BBDC |
| قاعدة البيانات: | BASE |
| تدمد: | 15587673 |
|---|---|
| DOI: | 10.1016/j.clgc.2018.02.016 |